In-Person Registration | Expert Second Opinion: Investigators Provide Perspectives on the Future Role of AKT Inhibition in the Management of Prostate Cancer
This activity is intended for medical and radiation oncologists, urologists and other healthcare providers involved in the treatment of prostate cancer.
You are now registering as a practicing physician, fellow, nurse or other healthcare provider involved in the treatment of cancer. If you are not a clinician in practice, please register as a nonclinician.